{"id":876884,"date":"2025-08-19T01:03:06","date_gmt":"2025-08-19T05:03:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/"},"modified":"2025-08-19T01:03:06","modified_gmt":"2025-08-19T05:03:06","slug":"argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/","title":{"rendered":"argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\" \/>\n<p align=\"justify\">\n        <strong>August 19, 2025<\/strong><\/p>\n<p>        <strong>Amsterdam, the Netherlands<\/strong> \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced it will host a webinar, titled \u201cR&amp;D Spotlight | Pioneering MuSK Biology with ARGX-119\u201d on Tuesday, September 16, 2025, at 2:00pm ET.<\/p>\n<p align=\"justify\">The webinar will be the first of a \u2018mini\u2019 series highlighting the argenx pipeline and research and development strategy. argenx management and scientific leadership will be joined by key opinion leaders, who will discuss the development of the MuSK agonist program, ARGX-119, and its potential to treat neuromuscular diseases, including congenital myasthenic syndromes (CMS), amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA).<\/p>\n<p align=\"justify\">A webcast of the event can be accessed on the Investors section of the argenx website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wxNQKqN1sp26X-pCElm4KYfC9gnMwfIaNhynJKhpl1_eZ66kfaOE0NhEvWD-c12j9ZCLsvmmeZckQFQhL7Jn7Ae-jPGPRTzeFJvm83e9K8lITQHh1B-Jvv-FS-pul_6-\" rel=\"nofollow\" target=\"_blank\">argenx.com\/investors<\/a>. A replay of the webcast will be available on the argenx website for approximately one year following the presentation.<\/p>\n<p align=\"justify\">\n        <strong>About argenx<\/strong>\n      <\/p>\n<p align=\"justify\">argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LUSu7Rsi4swtrN4h4acp1L1TXnO7QbYy4RbrnGGlRqUb6STVvZMfEdy4R031mkA9EPTFVonQv6cYEbN2ZnnubVeuVLxowFU8c8_YNiERhUuO9B6XoIFJa5kD7m8hOxwdK6kbABRUj2Ig6tgwhWtF4qk94y34C7JjEApV3NsZDcpaldJQH3RvdnRGyK3nz_XB63RqkDJ1wNnE9CVT5cmiu9CBG4z2ey5fwOBB4SB9r4_6dT1sYB3Sgq5T3S3ycnPJ6BzieFuEynSWY0-xL8YUPQ==\" rel=\"nofollow\" target=\"_blank\">www.argenx.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tcv8TmonJ5pVCg3y2wE-DNAG8N2usVQoMq_BDOgzE9kj-iwVegP1aVC8wZBAPts-9cY7cH42W3qrPdZpSapG90IqW_lc0oJ89tPmtHVI4rkiXroGcEI6W2DJs4mqqjgRYf6Vorw38CJIczJy6P3PynsvD1A1gW5GhGh9njcBnmOZp-Ft0xbHONdwbLRsAVAp92g5jnVN4Kn56ZSrx8A_vJhNPdwJC3qaQAVcn7GceUvrN24Ln8EQ81DLkXn6vx3RhMGLQBc6w21nnpwm-LQVCg==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_1JBYseFRBfA3pzG1ubvHi8y_ECT5CFgF8nscj9ehzwoJ6lmnoMOb_YmM7knaO8NuPqnslXZeQz25RBCao0zwWTd62-KldZC4rS6U6awaRzj7klemUJZavXXjyrMQC98-kadcAyMGGyX21uTtZgGzg_HJEeMI1zQqtUOVWO5VQk0FBphDCeWFiGGRzOGmyPedmhxZPBJf1tgNsvUTP33VGu-3F1JvhnAFmujDeWOGbfRdOWdAX22Q6KO72XxI4WmvwWYjUOr4owcX71VqvEzcg==\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=P2XHzHAd7DAuQ5D6ASshvNGdgvU2-8giLdhutChr3C1ySL0-Af-QDlhDTowTOBS6heMzp_7Vt_nc7picTjUKK_mtXG-1TSwF_NYHDwmsj4HOOdeLci9bfNxvbDHA8IQN_ZR3RBb6ti6d8oKsUip7E72HHVfds7sMfVM7MpIuo-qE0EyOxn5B1BTBGylt0-RWLBjPTZe_sO2w39Hc8dua6fgQaDPoA9uIFqnatjUeDS1KavgiLNwz0QTUx5ScE8OnPh0lIN3Zdtt0gv0ZBeY6iA==\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>, and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n2fBFuFu-s6mdL2kmeZa1iGNsNjEm1y6KSzFIxHg_zZzGpquhp2t6-7S0HR6AgKHS88Xmzn_qHS8vX_2VQn3Idn0RtZ-6-hqlxWbTNrIdovuiUV6zRJi0LrRdvs93wa0x45FJiFpPnbdCo_BGEcu9D1yQx_zqvUsOBArlLjH07-DQGc84sR_KdmKdcKiTtJu1E9hBsQd1zOCi1hDgt52yGrhWUlG5SIq7ghCqqxr5RokfeVSH7i2Kh0hDcu_ocVRYoAZ-m6Ae9ntg23dSW6cim2TA6Sq8dRqwFte_xXPLTg=\" rel=\"nofollow\" target=\"_blank\">YouTube<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Contacts<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Media:<\/strong>\n      <\/p>\n<p align=\"justify\">Colin McBean<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ydYeR0lZl_1cLUPi8uIH-I2ErFtQhKxNoJJb99QL7GkWkMIkbO_VXYdYOesklIwDh2_8514wfezPwPD4LpQenK7Y55MffA6rPhuMWlCCxpA=\" rel=\"nofollow\" target=\"_blank\">cmcbean@argenx.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Investors:<\/strong>\n      <\/p>\n<p align=\"justify\">Alexandra Roy<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7hAh_bExKzaLO-JHerucNrvBmHN_-v8Z1g41OPNUZU7oQNj7WX2JLXD8iQJDoBuuO2Pid0IS6ImevSAcjUjGkgBFCoygeTBnf1rm5kqDht4=\" rel=\"nofollow\" target=\"_blank\">aroy@argenx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMzQ2MiM0MDIxOTk5ODgjMjAwMzc3Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/MDVjZTU2ZGUtNmMwMi00NzgyLTllMTEtMzg1NjM0MDgxN2EwLTEwMTUzNDUtMjAyNS0wOC0xOS1lbg==\/tiny\/argenx-SE.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>August 19, 2025 Amsterdam, the Netherlands \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced it will host a webinar, titled \u201cR&amp;D Spotlight | Pioneering MuSK Biology with ARGX-119\u201d on Tuesday, September 16, 2025, at 2:00pm ET. The webinar will be the first of a \u2018mini\u2019 series highlighting the argenx pipeline and research and development strategy. argenx management and scientific leadership will be joined by key opinion leaders, who will discuss the development of the MuSK agonist program, ARGX-119, and its potential to treat neuromuscular diseases, including congenital myasthenic syndromes (CMS), amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). A webcast of the event &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-876884","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"August 19, 2025 Amsterdam, the Netherlands \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced it will host a webinar, titled \u201cR&amp;D Spotlight | Pioneering MuSK Biology with ARGX-119\u201d on Tuesday, September 16, 2025, at 2:00pm ET. The webinar will be the first of a \u2018mini\u2019 series highlighting the argenx pipeline and research and development strategy. argenx management and scientific leadership will be joined by key opinion leaders, who will discuss the development of the MuSK agonist program, ARGX-119, and its potential to treat neuromuscular diseases, including congenital myasthenic syndromes (CMS), amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). A webcast of the event &hellip; Continue reading &quot;argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-19T05:03:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMzQ2MiM0MDIxOTk5ODgjMjAwMzc3Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025\",\"datePublished\":\"2025-08-19T05:03:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\\\/\"},\"wordCount\":270,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyMzQ2MiM0MDIxOTk5ODgjMjAwMzc3Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\\\/\",\"name\":\"argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyMzQ2MiM0MDIxOTk5ODgjMjAwMzc3Mg==\",\"datePublished\":\"2025-08-19T05:03:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyMzQ2MiM0MDIxOTk5ODgjMjAwMzc3Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTEyMzQ2MiM0MDIxOTk5ODgjMjAwMzc3Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/","og_locale":"en_US","og_type":"article","og_title":"argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025 - Market Newsdesk","og_description":"August 19, 2025 Amsterdam, the Netherlands \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced it will host a webinar, titled \u201cR&amp;D Spotlight | Pioneering MuSK Biology with ARGX-119\u201d on Tuesday, September 16, 2025, at 2:00pm ET. The webinar will be the first of a \u2018mini\u2019 series highlighting the argenx pipeline and research and development strategy. argenx management and scientific leadership will be joined by key opinion leaders, who will discuss the development of the MuSK agonist program, ARGX-119, and its potential to treat neuromuscular diseases, including congenital myasthenic syndromes (CMS), amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). A webcast of the event &hellip; Continue reading \"argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-19T05:03:06+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMzQ2MiM0MDIxOTk5ODgjMjAwMzc3Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025","datePublished":"2025-08-19T05:03:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/"},"wordCount":270,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMzQ2MiM0MDIxOTk5ODgjMjAwMzc3Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/","name":"argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMzQ2MiM0MDIxOTk5ODgjMjAwMzc3Mg==","datePublished":"2025-08-19T05:03:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMzQ2MiM0MDIxOTk5ODgjMjAwMzc3Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTEyMzQ2MiM0MDIxOTk5ODgjMjAwMzc3Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-host-rd-webinar-highlighting-argx-119-on-september-16-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"argenx to Host R&amp;D Webinar Highlighting ARGX-119 on September 16, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/876884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=876884"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/876884\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=876884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=876884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=876884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}